Economy

Elon Musk’s Neuralink Lab Cited by FDA for Conditions- Report

Neuralink, the brain technology firm led by Elon Musk, has been cited by the Food and Drug Administration (FDA) for “objectionable conditions or practices” at its animal testing laboratory in California, Reuters reported.

This notice follows the company’s approval for a human brain implant study. The FDA’s discovery of the issues occurred in June 2023, shortly after Neuralink was permitted to conduct a limited study on its brain implant technology in humans.

The concerns regarding the animal testing facility were addressed in a letter to Congress on November 29, responding to issues raised by Representative Earl Blumenauer, an advocate for animal welfare from Oregon.

The FDA has urged Neuralink to implement voluntary corrective actions to remedy the conditions found. The agency has indicated that the issues, while warranting citations, were not significant enough to necessitate regulatory action. The FDA emphasized that the inspection did not reveal any violations that would compromise the safety of Neuralink’s devices.

In a statement, the FDA clarified that the citations were related to the documentation of animal research but did not specify the nature of the concerns. The agency’s inspection report from June 2023 had previously noted quality control and record-keeping issues at the facility, although it was unclear at the time what level of action would be required.

Neuralink has not publicly commented on whether it has addressed the FDA’s findings. The company has previously stated that its animal testing protocols exceed the requirements of current regulations.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

This post appeared first on investing.com

    Sign up and get the scoop before anyone else—fresh updates, and secret deals, all wrapped up just for you. We're talking juicy tips, fun surprises, and invites to events you actually want to go to. Don’t just watch from the sidelines—jump in and be part of the magic!

    By signing up, you're cool with getting emails from us. Don’t worry—your info stays safe, sound, and strictly confidential. No spam, no funny business. Just the good stuff.

    The Traders Intelligence
    Privacy Overview

    This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.